Papers
9
Total Citations
241
H-Index
7
About
Dr. Timo Soeterik is a leading researcher in urologic oncology, whose work is fundamentally reshaping how prostate cancer is staged and treated. His primary focus is on improving the accuracy of preoperative risk stratification, particularly for predicting extraprostatic extension (EPE) and lymph node involvement (LNI). Dr. Soeterik has made landmark contributions by developing and externally validating novel nomograms that integrate advanced imaging, such as multiparametric magnetic resonance imaging (mpMRI) and PSMA PET/CT, to guide surgical decision-making. His highly cited 2020 nomogram for side-specific EPE prediction (61 citations) and his demonstration that mpMRI should be preferred over digital rectal examination for local staging (57 citations) have directly influenced clinical guidelines. He has also critically evaluated surgical techniques, showing that nerve-sparing during robot-assisted radical prostatectomy increases the risk of positive surgical margins (55 citations). More recently, Dr. Soeterik has pioneered the use of artificial intelligence-driven models to enhance MRI-based EPE prediction, and his work on PSMA PET/CT for predicting biochemical recurrence represents the cutting edge of precision oncology. With over 240 total citations, his research is essential reading for any clinician or researcher aiming to personalize prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9